Form 4 for MRNA Moderna
Accepted 2022-05-02 00:00:00 ET · period of report 2022-04-28 · accession 0001127602-22-012856 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-02 | 2022-04-28 | MRNA | Tallett Elizabeth E | Dir | M - OptEx | $0.00 | +703 | 703 | New | $0 |
| D | 2022-05-02 | 2022-04-28 | MRNA | Tallett Elizabeth E | Dir | M - OptEx | $0.00 | -703 | 0 | -100% | $0 |
| D | 2022-05-02 | 2022-04-28 | MRNA | Tallett Elizabeth E | Dir | A - Grant | $0.00 | +5,415 | 5,415 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-28 | M | A | 703 | $0.00 | 703 | D | — | — | |
| 2 | Derivative | Restricted Stock Units | 2022-04-28 | M | D | 703 | $0.00 | 0 | D | $0.00 · — to — | 703 Common Stock | (F2) The shares subject to this restricted stock unit award vested in full on April 28, 2022. |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-04-28 | A | A | 5,415 | $0.00 | 5,415 | D | $142.52 · — to — | 5,415 Common Stock | (F3) This option will become fully vested and exercisable on the earlier of April 28, 2023, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. |